{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/25/3317441/0/en/Vivani-Medical-Receives-Regulatory-Approval-for-the-Initiation-of-SLIM-1-a-Phase-1-Clinical-Trial-of-NPM-139-Semaglutide-Implant-in-Obesity-and-Chronic-Weight-Management.html", "message": "News view counter 816250 successfully enlarged"}